You are here: Industry Insights > Prostate Cancer

News List

Hinova Announces First Patient Dosed in a Phase I Clinical Trial of HP518, an orally bioavailable Chimeric Degrader targeting Androgen Receptor for Prostate Cancer Treatment prnasia
January 21, 2022
Hinova Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cancers and metabolic diseases through targeted protein degradation technologies...
VA Study Shows Black Men Twice as Likely to Develop Prostate Cancer as Whites drugs.com
January 19, 2022
Even in a setting where white and Black people have equal access to medical care...
Newer Hormone Treatments for Prostate Cancer May Raise Risk of Depression drugs.com
January 18, 2022
Advanced forms of hormone therapy are very effective at keeping prostate cancer in check, but they also can double a man's risk of falling into depression, researchers have found.
Another clean interim safety review of RhoVac's clinical phase IIb study in prostate cancer prnasia
December 13, 2021
RhoVac AB ("RhoVac"), a Swedish cancer immunotherapy company, announces today on December 9th, 2021, that its Data & Safety Monitoring Committee (DSMC) has conducted a planned interim safety...
Statin Use Does Not Change Benefits of Prostate Cancer Screening Drugs
December 09, 2021
Prostate-specific antigen (PSA) screening is associated with a lower incidence of advanced prostate cancer regardless of statin use, according to a study published online Nov. 24 in JAMA Oncology.
Fifty percent recruitment milestone for PROPELLER prostate cancer trial prnasia
December 02, 2021
Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce that 15 of 30 participants...
Farrer Park Hospital Introduced Actinium-225 PSMA Nuclear Therapy for Advanced Prostate Cancer prnasia
November 01, 2021
Prostate cancer is the 3rd most common cancer among Singaporean men. Every day for years 2014-2018[1], 15% of new cancer cases for men were prostate cancer cases; more than 50% occurred among those aged 70 years and above.
NCCN Shares Latest Expert Recommendations for Prostate Cancer in Spanish and Portuguese prnewswire
September 13, 2021
During Prostate Cancer Awareness Month the National Comprehensive Cancer Network is announcing up-to-date, translated guidelines featuring recent advances in care for one of the most-common types of cancer
Clarity commences Cu-64/Cu-67 SAR-bisPSMA theranostic prostate cancer trial prnasia
July 29, 2021
Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has commenced its 64/67Cu SAR-bisPSMA theranostic clinical trial in patients with metastatic castrate ...
Obese Men May Have Better Survival With Advanced Prostate Cancer drugs
July 13, 2021
When men have advanced prostate cancer, obesity might offer something of a survival advantage, a preliminary study suggests.

Previous page 1 2 3 4 5 6 7 8 9 10 Next page